HIND

Vyome Holdings, Inc

Healthcare · Biotechnology

$63.13 sample

-0.48 (-0.75%) 1D

Market cap

$387.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-23

Alerts

8

Price$63.13 -8.89% 3M daily closessample

70.8663.08

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: Director
Oct 08INSInsider buy: Director
Oct 02INSInsider sell: General Counsel
Sep 28INSInsider buy: 10% owner
Sep 23SEC10-Q filed
Sep 15INSInsider buy: 10% owner
Sep 08SECForm 144 filed
Sep 03INSInsider buy: Chief Financial Officer

Sign up to see the real HIND record →

Company facts

SEC EDGAR registration

Name: Vyome Holdings, Inc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -14sample, -100 to +100
Reporting currency: USD

Who is positioning in HIND

sample

Insiders: 10 insider transactions over 90 days, net selling, $357.6M
Congress: 3 members traded over 90 days
Institutions · 13F: 10 funds hold $6.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.7B +18.6% y/y

Q4 2024Q3 2026

Inventory$9.5B +7.2% y/y

Q4 2024Q3 2026

Accounts receivable$7.4B +7.5% y/y

Q4 2024Q3 2026

Total debt$19.8B +16.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $87.9B +6.0% 3M
Sample peer B: $378.3B +15.7% 3M
Sample peer C: $129.8B -3.1% 3M
Sample peer D: $183.5B -4.0% 3M
Sample peer E: $227.1B +3.5% 3M